The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for JE Leysen


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
New 2-substituted 1,2,3,4-tetrahydrobenzofuro[3,2-c]pyridine having highly active and potent central alpha 2-antagonistic activity as potential antidepressants.EBI
Janssen Research Foundation
Design, synthesis, radiolabeling, and in vitro and in vivo evaluation of bridgehead iodinated analogues of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as potential SPECT ligands for the 5-HT1A receptor.EBI
Vu University Medical Center
Inhibitors of IRAK4 activityBDB
Merck Sharp & Dohme
Oxazoline and isoxazoline derivatives as CRAC modulatorsBDB
Lupin
Development of near-infrared fluorophore (NIRF)-labeled activity-based probes for in vivo imaging of legumain.BDB
Stanford University
Biarylether amide quinolines as liver X receptor agonists.BDB
Wyeth Research
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientation.BDB
Bristol-Myers Squibb
Novel tricyclic inhibitors of IkappaB kinase.BDB
Bristol-Myers Squibb